Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Prevention of Premature Luteinization in ICSI
NCT03088631Phase 2Completed
- Sponsor
- Assiut University
- Start
- Mar 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in Premature luteinization (PL), sponsored by Assiut University. Started Mar 2017; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Premature luteinization (PL)
Beyond the preview
Go deeper on NCT03088631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03088631.